Impact of chronic kidney disease on case ascertainment for hospitalised acute myocardial infarction: an English cohort studyPatrick Bidulka, Jemima Scott, Dominic M Taylor, Udaya Udayaraj, Fergus Caskey, Lucy Teece, Michael Sweeting, John Deanfield, Mark de Belder, Spiros Denaxas, Clive Weston, David Adlam, Dorothea Nitsch
28 March 2022
Evaluation of the design, conduct and reporting of randomised controlled trials in the haemodialysis population: a scoping review and interview studyPrachi Kaushal, Sherna F Adenwalla, Courtney J Lightfoot, Daniel S March, Laura J Gray, James O Burton
25 March 2022
Global eHealth capacity: secondary analysis of WHO data on eHealth and implications for kidney care delivery in low-resource settingsIkechi G Okpechi, Shezel Muneer, Feng Ye, Deenaz Zaidi, Anukul Ghimire, Mohammed M Tinwala, Syed Saad, Mohamed A Osman, Joseph Lunyera, Marcello Tonelli, Fergus Caskey, Cindy George, Andre P Kengne, Charu Malik, Sandrine DamsterSee the full list of authors
23 March 2022
Prevalence and risk factors associated with chronic kidney disease in Nepal: evidence from a nationally representative population-based cross-sectional studyAnil Poudyal, Khem Bahadur Karki, Namuna Shrestha, Krishna Kumar Aryal, Namra Kumar Mahato, Bihungum Bista, Laxmi Ghimire, Dirghayu KC, Pradip Gyanwali, Anjani Kumar Jha, Vanessa Garcia-Larsen, Ulrich Kuch, David A Groneberg, Sanjib Kumar Sharma, Meghnath Dhimal
21 March 2022
Results of a pilot feasibility randomised controlled trial exploring the use of an electronic patient-reported outcome measure in the management of UK patients with advanced chronic kidney diseaseDerek Kyte, Nicola Anderson, Jon Bishop, Andrew Bissell, Elizabeth Brettell, Melanie Calvert, Marie Chadburn, Paul Cockwell, Mary Dutton, Helen Eddington, Elliot Forster, Gabby Hadley, Natalie J Ives, Louise J Jackson, Sonia O'BrienSee the full list of authors
18 March 2022
Prevalence and associated factors of frailty among Southern Chinese Han patients on haemodialysis: a multicentre, observational cross-sectional studyWenyu Gong, Lirong Yao, Xiaoshi Zhong, Danping Qin, Chunrong Huang, Lianghong Yin, Fanna Liu
16 March 2022
Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trialSimeon Schietzel, Lia Bally, Grazia Cereghetti, Nicolas Faller, Matthias B Moor, Bruno Vogt, Felix Rintelen, S Trelle, Daniel Fuster
14 March 2022
Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO)Wesley Hayes, Emma Laing, Claire Foley, Laura Pankhurst, Helen Thomas, Helen Hume-Smith, Stephen Marks, Nicos Kessaris, William A Bryant, Anastassia Spiridou, Jo Wray, Mark J Peters
14 March 2022
Risk and incidence of cognitive impairment in patients with chronic kidney disease and diabetes: the results from a longitudinal study in a community cohort of patients and an age and gender-matched control cohort in North Wales, UKPeter Hobson, Mick Kumwenda, Siva Shrikanth, Hari Nair, Stephen Wong
11 March 2022
Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database studyLing Zhang, Sibylle Hauske, Yasuhisa Ono, Moe H Kyaw, Dominik Steubl, Yusuke Naito, Keizo Kanasaki
23 February 2022